Oric Pharmaceuticals Inc
F:4TZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oric Pharmaceuticals Inc
F:4TZ
|
US |
|
Clinuvel Pharmaceuticals Ltd
F:UR9A
|
AU |
|
G
|
Gazprom Neft' PAO
F:SCF
|
RU |
|
A
|
AAR Corp
F:ARZ
|
US |
|
Perma-Pipe International Holdings Inc
NASDAQ:PPIH
|
US |
|
A2A SpA
OTC:AEMMF
|
IT |
|
J
|
Jardine Cycle & Carriage Ltd
SWB:CYC
|
SG |
|
O
|
Optimi Health Corp
F:8BN
|
CA |
|
B
|
BBMG Corp
XMUN:9BM
|
CN |
|
A
|
Align Technology Inc
F:AFW
|
US |
|
E
|
elf Beauty Inc
F:0EF
|
US |
|
A
|
ARC Resources Ltd
F:8RC
|
CA |
|
I
|
IVU Traffic Technologies AG
OTC:IVUFF
|
DE |
|
I
|
Inghams Group Ltd
F:IH1
|
AU |
|
H
|
Huron Consulting Group Inc
F:HUR
|
US |
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
A
|
AO World PLC
SWB:81A
|
UK |
|
P
|
PTC Therapeutics Inc
F:P91
|
US |
|
Full Truck Alliance Co Ltd
F:892
|
CN |
Wall St Price Targets
4TZ Price Targets Summary
Oric Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
4TZ is 24.553 EUR with a low forecast of 17.672 EUR and a high forecast of 30.62 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4TZ's stock price target?
Price Target
24.553
EUR
According to Wall Street analysts, the average 1-year price target for
4TZ is 24.553 EUR with a low forecast of 17.672 EUR and a high forecast of 30.62 EUR.